investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of antibody-based cancer therapies

Mitchell Ho

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
To identify and validate new targets in hepatocellular carcinoma for antibody-based liver cancer therapy

Related projects

John Tavis

N-hydroxyisoquinolinediones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Geoffrey D Girnun

Metabolic control of hepatocellular carcinoma by PGC1alpha

Liver and intrahepatic bile ducts

Pathology

Shelly Chi-Loo Lu

Prohibitin 1 in Liver Injury and Cancer

Liver and intrahepatic bile ducts

Pathology

Frank Gonzalez

Xenobiotic Receptors – Rockville

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Role of Cancer Stem Cells in Liver Cancer Heterogeneity and Subtypes – Rockville

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Identification of Human Hepatocellular Carcinoma Metastasis Genes

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The role of cancer stem cells in Liver cancer heterogeneity and subtypes

Liver and intrahepatic bile ducts

Pathology

John Tavis

Alpha Hydroxytropolones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Tim Greten

Immune Suppressor Mechanism in a Murine Model of Hepatitis and Liver Cancer

Liver and intrahepatic bile ducts

Pathology